ReviewTargeted oncology2018

BIM Deletion Polymorphism Confers Resistance to Osimertinib in EGFR T790M Lung Cancer: a Case Report and Literature Review.

Xuanzong Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.